Scientists at Johns Hopkins University develop an artificial lymph node for cancer treatment with promising results in mice, combining with T-cells and anti-PD-1 drug.

Scientists at Johns Hopkins University have developed an artificial lymph node, a potential cancer treatment for humans, that acts as a learning hub and stimulator for immune system T-cells. The implanted device, made of hyaluronic acid, has shown promising results in mice with melanoma and colon cancers when combined with T-cells and the anti-PD-1 drug, offering a potentially more efficient treatment method than existing cell-based therapies. Further research and clinical trials are planned to evaluate the effectiveness and potential of the artificial lymph node in cancer treatment.